J- REVERSE: sirolimus-eluting vs. everolimus-eluting stent in bifurcation lesions

Asymmetrical expansion of the stent produces an uneven neointimal growth and increases the risk of thrombosis. The study was divided into two parts: the first one aimed at comparing, in the acute phase and the medium term, the result of provisional bifurcation stenting technique with sirolimus-eluting stent vs everolimus-eluting stent (both guided by IVUS); the second one aimed at investigating whether the asymmetric expansion can cause re-endothelialization issues.

The study included 229 patients with bifurcation lesions, of which 239 [SIC] received the everolimus-eluting stent (Xience V/Promus), and 60 received the sirolimus-eluting stent (Cypher Select). There were no significant differences in MACE (death, myocardial infarction, revascularization, or stent thrombosis) at 9 months between the two stents. Patients who underwent the kissing balloon technique had a higher rate of side branch dissection with the subsequent need for a second stent. 

Conclusion: Both stents were similar for treating bifurcations with provisional stent technique guided by IVUS. The kissing balloon technique increases the chance of side branch dissection and stent asymmetric expansion if the main branch, but decreases side branch restenosis and increased luminal diameter of the main branch after 9 months without changing the MACE.

yoshinobu_murasato_europcr
Yoshinobu Murasato.
2013-05-23

Original title: Mid-term results of Japanese registry study in comparison between everolimus-eluting stent and sirolimus-eluting stent for the bifurcation lesion (J- REVERSE). 

More articles by this author

Coronary obstruction registry after TAVI

There is little information in the literature about the obstruction of the coronary ostia after percutaneous aortic valve implantation. 81 TAVI sites and programs...

Clinical results of TAVI in Asia

Since all the studies available in the literature were conducted in North America or Europe, the results of percutaneous aortic valve replacement in Asia...

RIPCORD study: FFR changes clinical consideration of chest pain

The objective of this study was to evaluate whether routine use of FFR in all the coronary arteries could change the strategy in stable...

Coherex Wave Crest: New device for atrial appendage closure

Appendage closure devices have emerged as an alternative to anticoagulation in fibrillated patients with a contraindication for it. The study included 63 patients with...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long-Term Predictors of Valve Deterioration After TAVI

Transcatheter aortic valve implantation (TAVI) has become an innovative technology for the treatment of patients with severe aortic valve stenosis. Initially implemented in elderly...

Coronary access after TAVI with fourth- and fifth-generation Evolut valves: the EPROMPT-CA study

The expansion of transcatheter aortic valve implantation (TAVI) toward younger and lower-risk patients has increased the relevance of post-procedural coronary access. In this context,...

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...